The effects of darifenacin and tolterodine on heart rate (HR) in patients with overactive bladder (OAB)

被引：0
|
作者：
Olshansky, B.
Foote, J.
Arguinzoniz, M.
Lheritier, K.
Quebe-Fehling, E.
Steel, M.
机构：
[1] Univ Iowa Hosp, Iowa City, IA USA
[2] Midtown Urol & Surg Ctr, Atlanta, GA USA
[3] Novartis Pharma AG, Basel, Switzerland
来源：
NEUROUROLOGY AND URODYNAMICS | 2006年 / 25卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
124
引用
收藏
页码：656 / 657
页数：2
相关论文
共 50 条
  • [1] Impact of darifenacin compared with tolterodine on incontinence episodes in patients with overactive bladder
    Romanzi, LJ
    Delconte, A
    Kralidis, G
    OBSTETRICS AND GYNECOLOGY, 2005, 105 (04): : 88S - 88S
  • [2] A Study on Ocular Side Effects of Darifenacin and Trospium in Overactive Bladder (OAB): A Randomized, Pilot Study
    Manjunatha, R.
    Pundarikaksha, H. P.
    Hanumanthraju, B. K.
    Sowbhagya, H. N.
    Manjunath, N.
    INDIAN JOURNAL OF PHARMACOLOGY, 2014, 46 : S49 - S49
  • [3] COST-EFFECTIVENESS OF TOLTERODINE AS TREATMENT FOR OVERACTIVE BLADDER (OAB) IN ADULT MEXICAN PATIENTS
    Arreola-Ornelas, H.
    Rosado-Buzzo, A.
    Garcia-Mollinedo, M.
    Camacho-Cordero, L.
    Mucino-Ortega, E.
    Mould-Quevedo, J. F.
    Galindo-Suarez, R. M.
    VALUE IN HEALTH, 2011, 14 (03) : A76 - A76
  • [4] Safety and efficacy of tolterodine, solifenacin, and darifenacin in men with lower urinary tract symptoms (LOTS) on alpha-blockers with persistent overactive bladder symptoms (OAB)
    Kaplan, Steven A.
    Zoltan, Edward
    Te, Alexis E.
    JOURNAL OF UROLOGY, 2008, 179 (04): : 701 - 701
  • [5] The effects of darifenacin on the improvement of symptoms of overactive bladder among female patients
    不详
    JOURNAL OF ENDOUROLOGY, 2004, 18 : A107 - A107
  • [6] CLUSTERING OF PATIENTS WITH OVERACTIVE BLADDER (OAB) SYNDROME
    Lai, H.
    Paradis, A.
    Vetter, J.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2019, 30 : S279 - S279
  • [7] EFFICACY AND SAFETY OF TOLTERODINE EXTENDED RELEASE AND DUTASTERIDE IN MALE OVERACTIVE BLADDER (OAB) PATIENTS WITH PROSTATES: 30 GRAMS
    Chung, Doreen E.
    Te, Alexis E.
    Staskin, David R.
    Kaplan, Steven A.
    JOURNAL OF UROLOGY, 2009, 181 (04): : 697 - 697
  • [8] EFFECT OF DARIFENACIN (DAR) ON NUMBER OF DRY DAYS AND INCONTINENCE EPISODES/PAD USAGE IN "WET" OVERACTIVE BLADDER (OAB) PATIENTS
    Newman, Diane
    Aronstein, William
    Seifu, Yodit
    Larson-Peters, Andrea
    Mongay, Lidia
    NEUROUROLOGY AND URODYNAMICS, 2009, 28 (02) : 148 - 149
  • [9] Comparison of fesoterodine and tolterodine in patients with overactive bladder
    Chapple, Christopher R.
    Van Kerrebroeck, Philip E.
    Juenemann, Klaus-Peter
    Wang, Joseph T.
    Brodsky, Marina
    BJU INTERNATIONAL, 2008, 102 (09) : 1128 - 1132
  • [10] EFFECTS OF DARIFENACIN ON DRY DAYS IN OAB PATIENTS WITH URINARY INCONTINENCE (WET OAB PATIENTS)
    Newman, D.
    Seifu, Y.
    Larson-Peters, A.
    Rolli, M.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2009, 20 : S194 - S195
12345